S. LouisirirotchanakulC. WasiC. UneklabhT. PhutiprawanS. SuwanagoolT. ChainuvatiP. ThongcharoenMahidol University2018-06-142018-06-141988-06-01The Southeast Asian journal of tropical medicine and public health. Vol.19, No.2 (1988), 191-195012515622-s2.0-0024028637https://repository.li.mahidol.ac.th/handle/123456789/15623The prevalence of antibodies to delta virus (anti-delta) in the selected groups of hepatitis B surface antigenemia population was investigated. The subjects were 84 intravenous drug abusers; 20 chronic hepatitis, 12 cirrhosis, 6 primary hepatocellular carcinoma and 46 asymptomatic healthy carriers. Anti-delta was detected in 65.48% of intravenous drug abusers, 11.11% of chronic active hepatitis and 8.33% of cirrhosis cases. None of asymptomatic carriers had anti-delta. In addition, 51 acute icteric hepatitis B patients who were positive for HBs Ag and 20 IV drug abusers positive for anti-HBc only (HBsAg and anti-HBs negative) were negative for anti-delta.Mahidol UniversityMedicineArticleSCOPUS